Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AstraZeneca Mulls AaiPharma Omeprazole Patent; Will Not List Two Others

Executive Summary

AstraZeneca is expected to make a decision on whether to list an aaiPharma patent covering omeprazole in the "Orange Book" by the end of the month.
Advertisement

Related Content

Schwarz Omeprazole Launch Is Limited By Manufacturing Capacity
Schwarz Omeprazole Launch Is Limited By Manufacturing Capacity
FTC To Testify On Generic Reform; Agency Report May Be “Months” Away
FTC To Testify On Generic Reform; Agency Report May Be “Months” Away
Barr Fluoxetine Goal: 80% Generic Penetration In First Six Months
Prozac patent strategy
Prilosec Summary Judgment Narrows Scope Of Patent Infringement Case
Prilosec Summary Judgment Narrows Scope Of Patent Infringement Case
Advertisement
UsernamePublicRestriction

Register

PS038324

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel